Loading
Latest filing published 05 Jul 2022 for SQZ Biotechnologies Co, €6,284. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Armon Sharei appears in our data through filings on SQZ Biotechnologies Co shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 22 December 2021 to 30 June 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 5 July 2022 came the latest disclosure, a share grant for €6,284 in SQZ Biotechnologies Co. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations